Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery

Jul

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Menu

Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery

To read the full story....

Breaking News

AmoyDx, Premia Partner With Loxo on Genetic Testing for Cancer Therapy

Liquid Biopsy Assay From MSKCC Approved by New York State

IsoPlexis Wins $4M SBIR Grant From NCI

NICE Guidance Recommends Amgen's Blincyto for ALL Patients in Remission

Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug

Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer

Featured White Papers

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

What's Popular?

Liquid Biopsy Assay From MSKCC Approved by New York State

AmoyDx, Premia Partner With Loxo on Genetic Testing for Cancer Therapy

Liquid Biopsy Monitoring, Surveillance Efforts Accelerate Across Cancer Types and Technologies

Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms

IsoPlexis Wins $4M SBIR Grant From NCI

Sponsorships